Immunic Inc. (IMUX) Misses Q4 EPS by 53c
Tweet
Share
E-mailGet Alerts IMUX Hot Sheet
Join SI Premium – FREE
Immunic Inc. (NASDAQ: IMUX) reported Q4 EPS of ($0.62), $0.53 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- AeroVironment wins $500M defense contract
- Jackson Financial secures $1.25B revolving credit facility
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
